Markets · 1 sources covering this

Kardigan Files for IPO to Fund Cardiovascular Disease Treatment

Kardigan Inc. filed for a US initial public offering that will help fund three late-stage drugs that target the root cause of cardiovascular diseases.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
Kardigan Files for IPO to Fund Cardiovascular Disease Treatment
Kardigan Inc. filed for a US initial public offering that will help fund three late-stage drugs that target the root cause of cardiovascular diseases.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/a415ce6d97504352130876322f84c417fa304f8c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Kardigan Files for IPO to Fund Cardiovascular Disease Treatment"></iframe>

Kardigan Files for IPO to Fund Cardiovascular Disease Treatment

How 1 sources are covering this

Kardigan Files for IPO to Fund Cardiovascular Disease Treatment

More from Markets

Trump Backs CFTC as Prediction Market Regulator Amid State Fight

SpaceX IPO Gets Another Greenlight Toward Faster Index Inclusion

‘The timing couldn’t have been better’ for investors in MSGS as the Knicks make the NBA Finals

Asian Stocks Set to Rise as Iran Deal Hopes Hold: Markets Wrap

Reader

Trust & legal

Across the network

How 1 sources are covering this

Kardigan Files for IPO to Fund Cardiovascular Disease Treatment

More from Markets

Trump Backs CFTC as Prediction Market Regulator Amid State Fight

SpaceX IPO Gets Another Greenlight Toward Faster Index Inclusion

&#x2018;The timing couldn&#x2019;t have been better&#x2019; for investors in MSGS as the Knicks make the NBA Finals

Asian Stocks Set to Rise as Iran Deal Hopes Hold: Markets Wrap

Reader

Trust & legal

Across the network

‘The timing couldn’t have been better’ for investors in MSGS as the Knicks make the NBA Finals